Report Detail

Request for Sample of this report

Pharma & Healthcare Global Equine Chorionic Gonadotropin (eCG) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4580842
    • |
  • 29 March, 2024
    • |
  • Global
    • |
  • 95 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Equine Chorionic Gonadotropin (eCG) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. It is a glycoprotein hormone secreted by fetal-origin trophoblastic epithelial cells that form the endometrial cups.
The Global Info Research report includes an overview of the development of the Equine Chorionic Gonadotropin (eCG) industry chain, the market status of Infertility Treatment (Lyophilized Powder, Liquid Form), Reproduction Assistance (Lyophilized Powder, Liquid Form), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Equine Chorionic Gonadotropin (eCG).
Regionally, the report analyzes the Equine Chorionic Gonadotropin (eCG) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Equine Chorionic Gonadotropin (eCG) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Equine Chorionic Gonadotropin (eCG) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Equine Chorionic Gonadotropin (eCG) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M IU), revenue generated, and market share of different by Type (e.g., Lyophilized Powder, Liquid Form).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Equine Chorionic Gonadotropin (eCG) market.
Regional Analysis: The report involves examining the Equine Chorionic Gonadotropin (eCG) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Equine Chorionic Gonadotropin (eCG) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Equine Chorionic Gonadotropin (eCG):
Company Analysis: Report covers individual Equine Chorionic Gonadotropin (eCG) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Equine Chorionic Gonadotropin (eCG) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infertility Treatment, Reproduction Assistance).
Technology Analysis: Report covers specific technologies relevant to Equine Chorionic Gonadotropin (eCG). It assesses the current state, advancements, and potential future developments in Equine Chorionic Gonadotropin (eCG) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Equine Chorionic Gonadotropin (eCG) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Equine Chorionic Gonadotropin (eCG) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Lyophilized Powder
Liquid Form
Market segment by Application
Infertility Treatment
Reproduction Assistance
Major players covered
MSD Animal Health
Phiphar Healthcare Limited
RayBiotech
Ceva Santé Animale
Antech
Gansu Tianqi Biological Technology
Xiamen Origin Biotech
Cixi No.2 Hormones Factory
Biorigin (Beijing) Inc.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Equine Chorionic Gonadotropin (eCG) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Equine Chorionic Gonadotropin (eCG), with price, sales, revenue and global market share of Equine Chorionic Gonadotropin (eCG) from 2019 to 2024.
Chapter 3, the Equine Chorionic Gonadotropin (eCG) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Chorionic Gonadotropin (eCG) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Equine Chorionic Gonadotropin (eCG) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Equine Chorionic Gonadotropin (eCG).
Chapter 14 and 15, to describe Equine Chorionic Gonadotropin (eCG) sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Equine Chorionic Gonadotropin (eCG)
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Lyophilized Powder
    • 1.3.3 Liquid Form
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Infertility Treatment
    • 1.4.3 Reproduction Assistance
  • 1.5 Global Equine Chorionic Gonadotropin (eCG) Market Size & Forecast
    • 1.5.1 Global Equine Chorionic Gonadotropin (eCG) Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity (2019-2030)
    • 1.5.3 Global Equine Chorionic Gonadotropin (eCG) Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 MSD Animal Health
    • 2.1.1 MSD Animal Health Details
    • 2.1.2 MSD Animal Health Major Business
    • 2.1.3 MSD Animal Health Equine Chorionic Gonadotropin (eCG) Product and Services
    • 2.1.4 MSD Animal Health Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 MSD Animal Health Recent Developments/Updates
  • 2.2 Phiphar Healthcare Limited
    • 2.2.1 Phiphar Healthcare Limited Details
    • 2.2.2 Phiphar Healthcare Limited Major Business
    • 2.2.3 Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Product and Services
    • 2.2.4 Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Phiphar Healthcare Limited Recent Developments/Updates
  • 2.3 RayBiotech
    • 2.3.1 RayBiotech Details
    • 2.3.2 RayBiotech Major Business
    • 2.3.3 RayBiotech Equine Chorionic Gonadotropin (eCG) Product and Services
    • 2.3.4 RayBiotech Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 RayBiotech Recent Developments/Updates
  • 2.4 Ceva Santé Animale
    • 2.4.1 Ceva Santé Animale Details
    • 2.4.2 Ceva Santé Animale Major Business
    • 2.4.3 Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) Product and Services
    • 2.4.4 Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Ceva Santé Animale Recent Developments/Updates
  • 2.5 Antech
    • 2.5.1 Antech Details
    • 2.5.2 Antech Major Business
    • 2.5.3 Antech Equine Chorionic Gonadotropin (eCG) Product and Services
    • 2.5.4 Antech Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Antech Recent Developments/Updates
  • 2.6 Gansu Tianqi Biological Technology
    • 2.6.1 Gansu Tianqi Biological Technology Details
    • 2.6.2 Gansu Tianqi Biological Technology Major Business
    • 2.6.3 Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Product and Services
    • 2.6.4 Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Gansu Tianqi Biological Technology Recent Developments/Updates
  • 2.7 Xiamen Origin Biotech
    • 2.7.1 Xiamen Origin Biotech Details
    • 2.7.2 Xiamen Origin Biotech Major Business
    • 2.7.3 Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Product and Services
    • 2.7.4 Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Xiamen Origin Biotech Recent Developments/Updates
  • 2.8 Cixi No.2 Hormones Factory
    • 2.8.1 Cixi No.2 Hormones Factory Details
    • 2.8.2 Cixi No.2 Hormones Factory Major Business
    • 2.8.3 Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Product and Services
    • 2.8.4 Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Cixi No.2 Hormones Factory Recent Developments/Updates
  • 2.9 Biorigin (Beijing) Inc.
    • 2.9.1 Biorigin (Beijing) Inc. Details
    • 2.9.2 Biorigin (Beijing) Inc. Major Business
    • 2.9.3 Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Product and Services
    • 2.9.4 Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Biorigin (Beijing) Inc. Recent Developments/Updates

3 Competitive Environment: Equine Chorionic Gonadotropin (eCG) by Manufacturer

  • 3.1 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Equine Chorionic Gonadotropin (eCG) Revenue by Manufacturer (2019-2024)
  • 3.3 Global Equine Chorionic Gonadotropin (eCG) Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Equine Chorionic Gonadotropin (eCG) by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Equine Chorionic Gonadotropin (eCG) Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Equine Chorionic Gonadotropin (eCG) Manufacturer Market Share in 2023
  • 3.5 Equine Chorionic Gonadotropin (eCG) Market: Overall Company Footprint Analysis
    • 3.5.1 Equine Chorionic Gonadotropin (eCG) Market: Region Footprint
    • 3.5.2 Equine Chorionic Gonadotropin (eCG) Market: Company Product Type Footprint
    • 3.5.3 Equine Chorionic Gonadotropin (eCG) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Equine Chorionic Gonadotropin (eCG) Market Size by Region
    • 4.1.1 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2019-2030)
    • 4.1.3 Global Equine Chorionic Gonadotropin (eCG) Average Price by Region (2019-2030)
  • 4.2 North America Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)
  • 4.3 Europe Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)
  • 4.5 South America Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
  • 5.2 Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Type (2019-2030)
  • 5.3 Global Equine Chorionic Gonadotropin (eCG) Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
  • 6.2 Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Application (2019-2030)
  • 6.3 Global Equine Chorionic Gonadotropin (eCG) Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
  • 7.2 North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
  • 7.3 North America Equine Chorionic Gonadotropin (eCG) Market Size by Country
    • 7.3.1 North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
  • 8.2 Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
  • 8.3 Europe Equine Chorionic Gonadotropin (eCG) Market Size by Country
    • 8.3.1 Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Market Size by Region
    • 9.3.1 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
  • 10.2 South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
  • 10.3 South America Equine Chorionic Gonadotropin (eCG) Market Size by Country
    • 10.3.1 South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Market Size by Country
    • 11.3.1 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Equine Chorionic Gonadotropin (eCG) Market Drivers
  • 12.2 Equine Chorionic Gonadotropin (eCG) Market Restraints
  • 12.3 Equine Chorionic Gonadotropin (eCG) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Equine Chorionic Gonadotropin (eCG) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Equine Chorionic Gonadotropin (eCG)
  • 13.3 Equine Chorionic Gonadotropin (eCG) Production Process
  • 13.4 Equine Chorionic Gonadotropin (eCG) Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Equine Chorionic Gonadotropin (eCG) Typical Distributors
  • 14.3 Equine Chorionic Gonadotropin (eCG) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Equine Chorionic Gonadotropin (eCG). Industry analysis & Market Report on Equine Chorionic Gonadotropin (eCG) is a syndicated market report, published as Global Equine Chorionic Gonadotropin (eCG) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Equine Chorionic Gonadotropin (eCG) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,236.40
    		4,854.60
    		6,472.80
    		532,022.40
    		798,033.60
    		1,064,044.80
    		290,336.40
    		435,504.60
    		580,672.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo